Leiden, South Holland, Netherlands · On-site
We welcome open applications. So even if you don't see your dream job (or internship) listed, feel free to submit your application and we'd be happy to discuss the possibilities with you. As a growing company, we're alwa…
Leiden, South Holland, Netherlands · On-site
$4k–$6k/mo
Who are we looking for? Are you up for a challenging leadership role at a young and rapidly growing laboratory? Do you have proven experience in a relevant personnel management role, deep knowledge of Next Generation Seq…
Skills: Personnel Management, Next Generation Sequencing, Laboratory Leadership, Project Management, Automation Systems
Leiden, South Holland, Netherlands • On-site
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
Submit an open application to express interest in joining the company. Engage in discussions regarding potential roles that align with your skills and the company's mission.
Candidates should share the company's values and be excited about its mission and vision. The role is open to individuals with fresh perspectives and new ideas.
We welcome open applications. So even if you don't see your dream job (or internship) listed, feel free to submit your application and we'd be happy to discuss the possibilities with you. As a growing company, we're always on the lookout for new ideas and fresh perspectives!
Do you recognize yourself in our values? Are you excited to be part of a growing company that's passionate about its mission and vision?
Then we welcome your open application! Just click "Apply!"
Customizable Next Generation Sequencing solutions for your next pharma, healthcare, or academic research project.
Founded by research scientists and entrepreneurs in 2002, GenomeScan is a privately-owned company based in Leiden, The Netherlands. GenomeScan is a leading and innovative company in the field of genetic analyses. The company’s mission is to partner with hospitals, academic institutions, and global pharmaceutical and biotechnology companies to accelerate disease diagnostics and prediction, support clinician decision making, and improve the quality of life for patients suffering from genetic disorders. GenomeScan truly understands customers’ needs and develops tailored solutions. The company combines in-house expertise with a close collaboration with clinical experts from the prestigious Erasmus Medical Center and Leiden University Medical Center to develop an in-depth knowledge and understanding of a wide range of research methodologies and data-analysis and -interpretation relevant to clinical practice. In addition to providing patient stratification strategies based on NGS genetic profiling to pharmaceutical companies, GenomeScan’s services portfolio encompasses the latest sequencing technologies including whole exome sequencing, panel sequencing, transcriptomics, and epigenetics. GenomeScan maintains an accredited DNA testing facility (ISO/IEC 17025 accredited for NGS, also offering GCLP and GLP compliance for a variety of tests for large clinical and preclinical studies). The in-house laboratory is fully equipped to perform genetic tests for large clinical and drug development studies and deliver genetic profiles or diagnostics (including data interpretation) in 48 hours. Our industry-scale sequencers (NovaSeq 6000, PacBio Sequel), robotics and IT infrastructure have ample capacity to accommodate both research and diagnostics projects. An experienced bioinformatics team has developed pipelines for all our current services that can be customized to generate a comprehensive report tailored to your needs.
Offices: Plesmanlaan, 1d, Leiden, South Holland 2333 ZA, NL
Customizable Next Generation Sequencing solutions for your next pharma, healthcare, or academic research project.
Founded by research scientists and entrepreneurs in 2002, GenomeScan is a privately-owned company based in Leiden, The Netherlands. GenomeScan is a leading and innovative company in the field of genetic analyses. The company’s mission is to partner with hospitals, academic institutions, and global pharmaceutical and biotechnology companies to accelerate disease diagnostics and prediction, support clinician decision making, and improve the quality of life for patients suffering from genetic disorders. GenomeScan truly understands customers’ needs and develops tailored solutions. The company combines in-house expertise with a close collaboration with clinical experts from the prestigious Erasmus Medical Center and Leiden University Medical Center to develop an in-depth knowledge and understanding of a wide range of research methodologies and data-analysis and -interpretation relevant to clinical practice. In addition to providing patient stratification strategies based on NGS genetic profiling to pharmaceutical companies, GenomeScan’s services portfolio encompasses the latest sequencing technologies including whole exome sequencing, panel sequencing, transcriptomics, and epigenetics. GenomeScan maintains an accredited DNA testing facility (ISO/IEC 17025 accredited for NGS, also offering GCLP and GLP compliance for a variety of tests for large clinical and preclinical studies). The in-house laboratory is fully equipped to perform genetic tests for large clinical and drug development studies and deliver genetic profiles or diagnostics (including data interpretation) in 48 hours. Our industry-scale sequencers (NovaSeq 6000, PacBio Sequel), robotics and IT infrastructure have ample capacity to accommodate both research and diagnostics projects. An experienced bioinformatics team has developed pipelines for all our current services that can be customized to generate a comprehensive report tailored to your needs.
Offices: Plesmanlaan, 1d, Leiden, South Holland 2333 ZA, NL
